Advisors Preferred’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,130
Closed -$522K 242
2026
Q1
$522K Buy
6,130
+2,711
+79% +$242K 0.08% 136
2025
Q4
$266K Buy
3,419
+482
+16% +$37.8K 0.04% 158
2025
Q3
$232K Buy
+2,937
New +$251K 0.03% 187
2025
Q2
Sell
-7,508
Closed -$705K 208
2025
Q1
$705K Buy
7,508
+2,819
+60% +$252K 0.09% 134
2024
Q4
$425K Sell
4,689
-712
-13% -$67.9K 0.07% 123
2024
Q3
$553K Buy
5,401
+1,755
+48% +$179K 0.08% 114
2024
Q2
$348K Sell
3,646
-757
-17% -$69.8K 0.06% 95
2024
Q1
$392K Sell
4,403
-1,290
-23% -$109K 0.07% 86
2023
Q4
$460K Sell
5,693
-2,598
-31% -$195K 0.08% 99
2023
Q3
$587K Buy
8,291
+1,819
+28% +$136K 0.19% 87
2023
Q2
$499K Sell
6,472
-12
-0.2% -$929 0.12% 61
2023
Q1
$489K Sell
6,484
-1,199
-16% -$89.2K 0.17% 66
2022
Q4
$608K Sell
7,683
-94
-1% -$7.05K 0.26% 41
2022
Q3
$553K Sell
7,777
-611
-7% -$47.9K 0.28% 48
2022
Q2
$672K Buy
8,388
+1,877
+29% +$147K 0.18% 58
2022
Q1
$498K Buy
+6,511
New +$516K 0.04% 80
2015
Q4
Sell
-1,830
Closed -$116K 203
2015
Q3
$116K Buy
+1,830
New +$120K 0.13% 47

Other funds holding CL

Advisors Preferred's CL Position: Q2 2026 in Review

Advisors Preferred sold out of Colgate-Palmolive (CL) in Q2 2026, closing a stake of 6,130 shares — an estimated $522K sold.

Advisors Preferred first reported a position in CL in Q3 2015 and held it in 17 quarters. The position peaked at $705K in Q1 2025. 2,013 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Advisors Preferred reported no remaining Colgate-Palmolive position as of Q2 2026 after selling out during the quarter.
  • Advisors Preferred sold 6,130 Colgate-Palmolive shares in Q2 2026, an estimated $522K.
  • Advisors Preferred first reported a position in Colgate-Palmolive in Q3 2015 and held it in 17 quarters.
  • Advisors Preferred's Colgate-Palmolive position peaked at $705K in Q1 2025.
  • 2,013 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Advisors Preferred's 13F filing for Q2 2026, filed 11 Aug 2026.